Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
DNLI | Denali Therapeutics Inc. | President and CEO, Director | $67.5M | -$1.82M | -2.63% | Oct 18, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|